Latest news
AstraZeneca’s Datroway wins EU approval as first TROP2-directed therapy for breast cancer - Indian Pharma PostIndian Pharma Post · Wed, 05 Aug 2026 14:18:22 GMTFDA Green-Lights Five New Treatment Options for Breast Cancer - Cancer HealthCancer Health · Mon, 03 Aug 2026 13:01:12 GMTDatroway Wins EU Approval for First-Line Metastatic Triple-Negative Breast Cancer - BioPharm InternationalBioPharm International · Fri, 31 Jul 2026 17:17:31 GMTDaiichi Sankyo wins EU approval for Datroway in TNBC - jp.ibtimes.comjp.ibtimes.com · Fri, 31 Jul 2026 16:15:40 GMTEU approves Datroway as first TROP2 ADC with overall survival benefit in first-line metastatic TNBC - AllSciAllSci · Fri, 31 Jul 2026 12:33:31 GMTDatroway joins Trodelvy for frontline TNBC in the EU - pharmaphorumpharmaphorum · Fri, 31 Jul 2026 11:40:49 GMTDatroway approved in the EU for metastatic TNBC - The Pharma LetterThe Pharma Letter · Fri, 31 Jul 2026 11:19:47 GMTAstraZeneca and Daiichi win EU label expansion for Datroway in breast cancer - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 10:53:54 GMT